Invention Grant
- Patent Title: Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
-
Application No.: US13334869Application Date: 2011-12-22
-
Publication No.: US08410249B2Publication Date: 2013-04-02
- Inventor: Gerald B. Pier , Casie Anne Kelly-Quintos , Lisa Cavacini , Marshall R. Posner
- Applicant: Gerald B. Pier , Casie Anne Kelly-Quintos , Lisa Cavacini , Marshall R. Posner
- Applicant Address: US MA Boston US MA Boston
- Assignee: The Brigham and Women's Hospital, Inc.,Beth Israel Deaconess Medical Center, Inc.
- Current Assignee: The Brigham and Women's Hospital, Inc.,Beth Israel Deaconess Medical Center, Inc.
- Current Assignee Address: US MA Boston US MA Boston
- Agency: MKG, LLC
- Main IPC: C07K1/00
- IPC: C07K1/00 ; C07K16/00 ; C12P21/08

Abstract:
The present invention relates to peptides, particularly human monoclonal antibodies, that bind specifically to poly-N-acetyl glucosamine (PNAG), such as Staphylococcal PNAG, in acetylated, partially acetylated and/or fully deacetylated form. The invention further provides methods for using these peptides in the diagnosis, prophylaxis and therapy of infections by bacteria that express PNAG such as but not limited to Staphylococci and E. coli. Some antibodies of the invention enhance opsonophagocytic killing and in vivo protection against bacteria that express PNAG such as but not limited to Staphylococci and E. coli. Compositions of these peptides, including pharmaceutical compositions, are also provided, as are functionally equivalent variants of such peptides.
Public/Granted literature
- US20120201834A1 POLY-N-ACETYL GLUCOSAMINE (PNAG/dPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF Public/Granted day:2012-08-09
Information query